Logo

American Heart Association

  56
  0


Final ID:

Gene Therapies for Cardiac and Muscular Diseases

  • Mcnally, Elizabeth  ( NORTHWESTERN UNIVERSITY , Chicago , Illinois , United States )
  • Adler, Eric  ( Ucsd , La Jolla , California , United States )
  • Hajjar, Roger  ( Massachusetts General Brigham , Cambridge , Massachusetts , United States )
  • Author Disclosures:
    Elizabeth McNally: DO have relevant financial relationships ; Consultant:Tenaya Therapeutics:Past (completed) ; Other (please indicate in the box next to the company name):Novartis:Active (exists now) ; Consultant:PepGene:Active (exists now) | Eric Adler: DO have relevant financial relationships ; Executive Role:Lexeo Therapeutics:Active (exists now) ; Ownership Interest:Papillion Therapeutics:Active (exists now) ; Ownership Interest:Rocket Pharmaceuticals:Active (exists now) | Roger Hajjar: DO have relevant financial relationships ; Ownership Interest:AskBio:Past (completed) ; Advisor:Atamayo:Active (exists now) ; Advisor:Longeveron:Active (exists now) ; Ownership Interest:Medera:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Innovation at the Bench to Prime-Time Therapies at the Bedside

Monday, 11/10/2025 , 08:00AM - 09:15AM

Cardiovascular Seminar

More abstracts on this topic:
Disrupting the Central Dogma of Molecular Biology with RNA Interference

Kalra Dinesh, Chan Stephen, Keaney John, Poller Wolfgang

Re-writing the Code Using CRISPR-Based Gene Editing in Cardiovascular Disease

Musunuru Kiran, Fontana Marianna, Seidman Christine, Seidman Jonathan

You have to be authorized to contact abstract author. Please, Login
Not Available